Quest Diagnostics, Inc. (DGX) Tops Q4 EPS Views; Guides FY12 EPS Below Views
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $237.14 -0.94%
EPS Growth %: +10.0%
Financial Fact:
Equity earnings in unconsolidated joint ventures: 11M
Today's EPS Names:
PMCB, CULP, HURC, More
EPS Growth %: +10.0%
Financial Fact:
Equity earnings in unconsolidated joint ventures: 11M
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
Quest Diagnostics, Inc. (NYSE: DGX) reported Q4 EPS of $1.19, 13 cents better than the analyst estimate of $1.06. Revenue for the quarter came in at $1.88 billion versus the consensus estimate of $1.86 billion.
Quest Diagnostics, Inc. sees FY2012 EPS of $4.40-$4.55, versus the consensus of $4.66.
For earnings history and earnings-related data on Quest Diagnostics, Inc. (DGX) click here.
Quest Diagnostics, Inc. sees FY2012 EPS of $4.40-$4.55, versus the consensus of $4.66.
For earnings history and earnings-related data on Quest Diagnostics, Inc. (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- StoneX Reiterates Hold Rating on Old Dominion Freight Line (ODFL) on QTD Operating Metrics
- SoundHound AI completes LivePerson acquisition, names new CFO
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
